CYP2C9 and pulmonary hypertension, primary, 1: Ethnic-specific genetic variation database is vital to identification of good pharmacogenetic markers in Asian countries such as CYP2C9*3 associated with PHT-induced SJS/TEN in Taiwanese, Japanese, and Malaysians (Chung et al., 2014).